Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling

[1]  K. K. Mahapatra,et al.  Inflammasomes in cancer: Effect of epigenetic and autophagic modulations. , 2020, Seminars in cancer biology.

[2]  Martin J. Aryee,et al.  Large-Scale Topological Changes Restrain Malignant Progression in Colorectal Cancer , 2020, Cell.

[3]  Teruhiko Yoshida,et al.  Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis , 2020, Epigenetics.

[4]  H. Kume,et al.  Establishment of permutation for cancer risk estimation in the urothelium based on genome-wide DNA methylation analysis. , 2019, Carcinogenesis.

[5]  Analysis of Heterogeneity , 2019, Who Wants What?.

[6]  Hui Liu,et al.  An analysis about heterogeneity among cancers based on the DNA methylation patterns , 2019, BMC Cancer.

[7]  Wei Li,et al.  Identification of key genes and pathways downstream of the β-catenin-TCF7L1 complex in pancreatic cancer cells using bioinformatics analysis , 2019, Oncology letters.

[8]  Mengtao Zhou,et al.  The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma , 2019, Cancer Cell International.

[9]  Y. Kanai,et al.  Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer , 2019, Carcinogenesis.

[10]  J. Ji,et al.  LINC00707 contributes to hepatocellular carcinoma progression via sponging miR‐206 to increase CDK14 , 2018, Journal of cellular physiology.

[11]  Roberto J. Rivero-Soto,et al.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma. , 2019, Annals of Surgery.

[12]  Roberto J. Rivero-Soto,et al.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma. , 2019, Annals of surgery.

[13]  Thierry Lecomte,et al.  FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer , 2018, The New England journal of medicine.

[14]  G. Honda,et al.  A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study , 2018, Journal of Gastroenterology.

[15]  Jeffrey W. Clark,et al.  Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial , 2018, JAMA oncology.

[16]  S. Natsugoe,et al.  A Therapeutic Strategy for Resectable Pancreatic Cancer Based on Risk Factors of Early Recurrence , 2018, Pancreas.

[17]  Y. Kanai,et al.  Novel method for DNA methylation analysis using high‐performance liquid chromatography and its clinical application , 2018, Cancer science.

[18]  Y. Miyagi,et al.  The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses , 2018, Pathology international.

[19]  Kiyotsugu Yoshida,et al.  Downregulation of dual‐specificity tyrosine‐regulated kinase 2 promotes tumor cell proliferation and invasion by enhancing cyclin‐dependent kinase 14 expression in breast cancer , 2018, Cancer science.

[20]  J. Cameron,et al.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma , 2017, Annals of surgery.

[21]  B. Dörken,et al.  CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Büchler,et al.  Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial , 2017, The Lancet.

[23]  Y. Kanai,et al.  Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis , 2017, Carcinogenesis.

[24]  K. Hirakawa,et al.  Preoperative predictors for early recurrence of resectable pancreatic cancer , 2017, World Journal of Surgical Oncology.

[25]  N. Cho,et al.  Improved results of LINE-1 methylation analysis in formalin-fixed, paraffin-embedded tissues with the application of a heating step during the DNA extraction process , 2017, Clinical Epigenetics.

[26]  Peter A. Jones,et al.  Targeting the cancer epigenome for therapy , 2016, Nature Reviews Genetics.

[27]  Peter A. Jones,et al.  Epigenetic Determinants of Cancer. , 2016, Cold Spring Harbor perspectives in biology.

[28]  Xiangfu Sun,et al.  Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway , 2016, Gynecologic and Obstetric Investigation.

[29]  N. Sata,et al.  Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01) , 2016, The Lancet.

[30]  尾原 健太郎.  Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs : a single-institutional methylome analysis using 1007 tissue specimens(審査報告) , 2016 .

[31]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[32]  G. Honda,et al.  Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[33]  Suman Lee,et al.  Epigenetic instability of imprinted genes in human cancers , 2015, Nucleic acids research.

[34]  K. Okamura,et al.  Changepoint detection in base-resolution methylome data reveals a robust signature of methylated domain landscape , 2015, BMC Genomics.

[35]  Xiubing Zhang,et al.  Knockdown of PFTK1 Inhibits the Migration of Glioma Cells , 2015, Journal of Molecular Neuroscience.

[36]  Teruhiko Yoshida,et al.  Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome , 2014, Carcinogenesis.

[37]  Jianmin Wu,et al.  Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling , 2014, International journal of cancer.

[38]  T. Betsuyaku,et al.  Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease , 2013, International journal of cancer.

[39]  Masao Tanaka,et al.  Japan Pancreatic Cancer Registry; 30th Year Anniversary: Japan Pancreas Society , 2012, Pancreas.

[40]  Y. Kanai,et al.  Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas , 2012, Carcinogenesis.

[41]  H. Furukawa,et al.  Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[42]  Y. Kanai,et al.  Carcinogenetic risk estimation based on quantification of DNA methylation levels in liver tissue at the precancerous stage , 2011, International journal of cancer.

[43]  W. Samlowski,et al.  A single-arm phase II trial evaluating docetaxel, vinorelbine, and GM-CSF in stage IV melanoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  F. Hosoda,et al.  Diagnosis and Prognostication of Ductal Adenocarcinomas of the Pancreas Based on Genome-Wide DNA Methylation Profiling by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification , 2010, Journal of biomedicine & biotechnology.

[45]  S. Hirohashi,et al.  Genome‐wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma , 2009, International journal of cancer.

[46]  K. Gunderson,et al.  Genome-wide DNA methylation profiling using Infinium® assay. , 2009, Epigenomics.

[47]  R. Hruban,et al.  Precursors to pancreatic cancer. , 2007, Gastroenterology clinics of North America.

[48]  Manal M. Hassan,et al.  Risk Factors for Pancreatic Cancer: Case-Control Study , 2007, The American Journal of Gastroenterology.

[49]  S. Hirohashi,et al.  DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. , 2006, Carcinogenesis.

[50]  S. Hirohashi,et al.  Increased DNA methyltransferase 1 (DNMT1) protein expression in precancerous conditions and ductal carcinomas of the pancreas , 2005, Cancer science.

[51]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.